233 related articles for article (PubMed ID: 28423659)
1. Targeting HOX/PBX dimers in cancer.
Morgan R; El-Tanani M; Hunter KD; Harrington KJ; Pandha HS
Oncotarget; 2017 May; 8(19):32322-32331. PubMed ID: 28423659
[TBL] [Abstract][Full Text] [Related]
2. Targeting the HOX/PBX dimer in breast cancer.
Morgan R; Boxall A; Harrington KJ; Simpson GR; Gillett C; Michael A; Pandha HS
Breast Cancer Res Treat; 2012 Nov; 136(2):389-98. PubMed ID: 23053648
[TBL] [Abstract][Full Text] [Related]
3. Targeting HOX/PBX dimer formation as a potential therapeutic option in esophageal squamous cell carcinoma.
Shen LY; Zhou T; Du YB; Shi Q; Chen KN
Cancer Sci; 2019 May; 110(5):1735-1745. PubMed ID: 30844117
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cancer cell proliferation by designed peptide amphiphiles.
Aulisa L; Forraz N; McGuckin C; Hartgerink JD
Acta Biomater; 2009 Mar; 5(3):842-53. PubMed ID: 19249722
[TBL] [Abstract][Full Text] [Related]
5. Targeting HOX and PBX transcription factors in ovarian cancer.
Morgan R; Plowright L; Harrington KJ; Michael A; Pandha HS
BMC Cancer; 2010 Mar; 10():89. PubMed ID: 20219106
[TBL] [Abstract][Full Text] [Related]
6. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1.
Calvo KR; Knoepfler P; McGrath S; Kamps MP
Oncogene; 1999 Dec; 18(56):8033-43. PubMed ID: 10637514
[TBL] [Abstract][Full Text] [Related]
7. Targeting HOX transcription factors in prostate cancer.
Morgan R; Boxall A; Harrington KJ; Simpson GR; Michael A; Pandha HS
BMC Urol; 2014 Feb; 14():17. PubMed ID: 24499138
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of HOX/PBX dimer formation leads to necroptosis in acute myeloid leukemia cells.
Alharbi RA; Pandha HS; Simpson GR; Pettengell R; Poterlowicz K; Thompson A; Harrington K; El-Tanani M; Morgan R
Oncotarget; 2017 Oct; 8(52):89566-89579. PubMed ID: 29163771
[TBL] [Abstract][Full Text] [Related]
9. HOX transcription factors are potential targets and markers in malignant mesothelioma.
Morgan R; Simpson G; Gray S; Gillett C; Tabi Z; Spicer J; Harrington KJ; Pandha HS
BMC Cancer; 2016 Feb; 16():85. PubMed ID: 26867567
[TBL] [Abstract][Full Text] [Related]
10. The highest affinity DNA element bound by Pbx complexes in t(1;19) leukemic cells fails to mediate cooperative DNA-binding or cooperative transactivation by E2a-Pbx1 and class I Hox proteins - evidence for selective targetting of E2a-Pbx1 to a subset of Pbx-recognition elements.
Knoepfler PS; Kamps MP
Oncogene; 1997 May; 14(21):2521-31. PubMed ID: 9191052
[TBL] [Abstract][Full Text] [Related]
11. Lock and key binding of the HOX YPWM peptide to the PBX homeodomain.
Sprules T; Green N; Featherstone M; Gehring K
J Biol Chem; 2003 Jan; 278(2):1053-8. PubMed ID: 12409300
[TBL] [Abstract][Full Text] [Related]
12. HOX genes and their role in the development of human cancers.
Bhatlekar S; Fields JZ; Boman BM
J Mol Med (Berl); 2014 Aug; 92(8):811-23. PubMed ID: 24996520
[TBL] [Abstract][Full Text] [Related]
13. Targeting HOX-PBX interactions causes death in oral potentially malignant and squamous carcinoma cells but not normal oral keratinocytes.
Platais C; Radhakrishnan R; Niklander Ebensperger S; Morgan R; Lambert DW; Hunter KD
BMC Cancer; 2018 Jul; 18(1):723. PubMed ID: 29980182
[TBL] [Abstract][Full Text] [Related]
14. Cellular proliferation and transformation induced by HOXB4 and HOXB3 proteins involves cooperation with PBX1.
Krosl J; Baban S; Krosl G; Rozenfeld S; Largman C; Sauvageau G
Oncogene; 1998 Jul; 16(26):3403-12. PubMed ID: 9692548
[TBL] [Abstract][Full Text] [Related]
15. HoxB8 requires its Pbx-interaction motif to block differentiation of primary myeloid progenitors and of most cell line models of myeloid differentiation.
Knoepfler PS; Sykes DB; Pasillas M; Kamps MP
Oncogene; 2001 Sep; 20(39):5440-8. PubMed ID: 11571641
[TBL] [Abstract][Full Text] [Related]
16. [Identification of proteins associated with transcription factors HOXA9 and E2A-PBX1 by tandem affinity purification].
Shestakova EA; Boutin M; Bourassa S; Bonneil E; Bijl JJ
Mol Biol (Mosk); 2017; 51(3):490-501. PubMed ID: 28707666
[TBL] [Abstract][Full Text] [Related]
17. Disrupting the interaction between HOX and PBX causes necrotic and apoptotic cell death in the renal cancer lines CaKi-2 and 769-P.
Shears L; Plowright L; Harrington K; Pandha HS; Morgan R
J Urol; 2008 Nov; 180(5):2196-201. PubMed ID: 18804814
[TBL] [Abstract][Full Text] [Related]
18. PBX proteins: much more than Hox cofactors.
Laurent A; Bihan R; Omilli F; Deschamps S; Pellerin I
Int J Dev Biol; 2008; 52(1):9-20. PubMed ID: 18033668
[TBL] [Abstract][Full Text] [Related]
19. The homeodomain region controls the phenotype of HOX-induced murine leukemia.
Breitinger C; Maethner E; Garcia-Cuellar MP; Slany RK
Blood; 2012 Nov; 120(19):4018-27. PubMed ID: 22990017
[TBL] [Abstract][Full Text] [Related]
20. HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer).
Plowright L; Harrington KJ; Pandha HS; Morgan R
Br J Cancer; 2009 Feb; 100(3):470-5. PubMed ID: 19156136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
